VapBC (virulence associated proteins B and C) is the largest family of type II toxin-antitoxin systemgenetic loci in prokaryotes.[1] VapBC operons consist of two genes: VapC encodes a toxic PilT N-terminus (PIN) domain, and VapB encodes a matching antitoxin.[2] The toxins in this family are thought to perform RNA cleavage, which is inhibited by the co-expression of the antitoxin, in a manner analogous to a poison and antidote.
First discovered in 1992, vapBC loci are now thought make up around 37–42% of all type II toxin-antitoxin systems.[3][4]
Discovery
Following the discoveries of two other type II toxin-antitoxin systems,[5][6] the first vapBC system to be characterised was found in Salmonella dublin strain G19 in 1992.[7] It was characterised as a system for ensuring that all daughter cells contained a copy of the plasmid encoding the vapBC locus. The two components of this plasmidic system were originally named vagC and vagD (virulence-associated gene) for the toxin and antitoxin genes respectively. VagC was predicted to encode a 12kDa polypeptide, while vagD encoded a smaller 10kDa protein.[7] Their open reading frames were found to overlap by a single nucleotide; suggesting they were translated together, and at a constant molar ratio.[8]
Distribution
VapBC operons have been found in distantly related prokaryotes, including the pathogens Leptospira interrogans,[9]Mycobacterium tuberculosis[10] and Piscirickettsia salmonis.[11] The loci have been described as "surprisingly abundant, especially in Archaea"[12]—vapBC family members made up 37% of all TA families identified by one bioinformatics search[3] and 42% of those found by another.[4]
VapC toxins, specifically the PIN domains, act as ribonucleases in cleaving RNA molecules, thereby reducing the rate of translation.[10][14] In the bacteria Shigella flexneri and Salmonella enterica, VapC toxins have been shown to perform specific cleavage of a tRNA, but in other bacteria the RNA cleavage may be less specific.[15] The specificity of VapC-mediated RNase activity is thought to be influenced by both the primary sequence of the target and secondary structural motifs.[16]
VapC is strongly inhibited by direct protein interaction with VapB, its cognate antitoxin. The toxin-antitoxin complex is thought to autoregulate its own operon, repressing transcription of both components through a DNA-binding domain in VapB.[17]
In some organisms, vapBC loci have been assigned other potential functions. In the hyperthermophilic archaean Sulfolobus solfataricus, for example, a vapBC gene cassette is thought to regulate heat shock response.[2]
^Robson, Jennifer; McKenzie, Joanna L.; Cursons, Ray; Cook, Gregory M.; Arcus, Vickery L. (17 July 2009). "The vapBC Operon from Mycobacterium smegmatis Is An Autoregulated Toxin–Antitoxin Module That Controls Growth via Inhibition of Translation". Journal of Molecular Biology. 390 (3): 353–367. doi:10.1016/j.jmb.2009.05.006. PMID19445953.
^Bravo, A; de Torrontegui, G; Díaz, R (Nov 1987). "Identification of components of a new stability system of plasmid R1, ParD, that is close to the origin of replication of this plasmid". Molecular & General Genetics. 210 (1): 101–10. doi:10.1007/bf00337764. PMID3323833. S2CID5624001.
^ abPullinger, GD; Lax, AJ (Jun 1992). "A Salmonella dublin virulence plasmid locus that affects bacterial growth under nutrient-limited conditions". Molecular Microbiology. 6 (12): 1631–43. doi:10.1111/j.1365-2958.1992.tb00888.x. PMID1495391. S2CID42047496.
^Van Melderen, Laurence (1 December 2010). "Toxin–antitoxin systems: why so many, what for?". Current Opinion in Microbiology. 13 (6): 781–785. doi:10.1016/j.mib.2010.10.006. PMID21041110.
^Sharrock, A.V. (2013) Characterisation of VapBC Toxin-Antitoxins from Mycobacterium tuberculosis. Unpublished Masters Thesis, University of Waikato, Hamilton, New Zealand http://hdl.handle.net/10289/7935